Jefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Jefferies analyst Matthew Stanton initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Hold rating and announces Price Target of $150.
Jefferies analyst Matthew Stanton initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Hold rating and announces Price Target of $150.